Does DEGARELIX Cause Injection site erythema? 246 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 246 reports of Injection site erythema have been filed in association with DEGARELIX (FIRMAGON). This represents 6.5% of all adverse event reports for DEGARELIX.
246
Reports of Injection site erythema with DEGARELIX
6.5%
of all DEGARELIX reports
6
Deaths
46
Hospitalizations
How Dangerous Is Injection site erythema From DEGARELIX?
Of the 246 reports, 6 (2.4%) resulted in death, 46 (18.7%) required hospitalization, and 1 (0.4%) were considered life-threatening.
Is Injection site erythema Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DEGARELIX. However, 246 reports have been filed with the FAERS database.
What Other Side Effects Does DEGARELIX Cause?
Injection site pain (296)
Hot flush (199)
Fatigue (195)
Injection site swelling (183)
Product storage error (177)
Pyrexia (170)
Off label use (128)
Asthenia (123)
Death (120)
Injection site mass (118)
What Other Drugs Cause Injection site erythema?
ETANERCEPT (17,736)
DUPILUMAB (8,818)
ADALIMUMAB (8,563)
TIRZEPATIDE (3,844)
TERIPARATIDE (3,453)
GLATIRAMER (2,560)
IXEKIZUMAB (2,144)
ENBREL (1,879)
EVOLOCUMAB (1,754)
HUMIRA (1,654)
Which DEGARELIX Alternatives Have Lower Injection site erythema Risk?
DEGARELIX vs DELAFLOXACIN MEGLUMINE
DEGARELIX vs DELAMANID
DEGARELIX vs DELANDISTROGENE MOXEPARVOVEC-ROKL
DEGARELIX vs DELAVIRDINE
DEGARELIX vs DELORAZEPAM